Related by context. All words. (Click for frequent words.) 77 QT prolongation 76 Hypotension 73 hepatotoxicity 72 β blockers 72 hypercalcemia 72 EXJADE 72 TEAEs 72 prolonged QT interval 71 hematologic toxicity 71 torsade de pointes 71 AST ALT 71 hepatic toxicity 71 endometrial hyperplasia 71 thromboembolic events 71 torsades de pointes 71 APTIVUS r 71 ALT flares 70 cytopenias 70 Hepatotoxicity 70 clomipramine 70 NATRECOR ® 70 flecainide 70 glycated hemoglobin levels 70 haematologic 70 transaminase elevations 70 cerebrovascular events 70 QTc 70 concomitant medications 70 bone marrow suppression 70 rFVIIa 70 severe hypersensitivity reactions 69 hematological toxicity 69 Torsades de Pointes 69 idraparinux 69 ziconotide 69 bovine thrombin 69 hemorrhagic complications 69 mycophenolate mofetil 69 posaconazole 69 efalizumab 69 DLTs 69 symptomatic VTE 69 fluvastatin 69 hypophosphatemia 69 pentoxifylline 69 aminotransferases 69 Dasatinib 69 Serious adverse reactions 69 postoperative complication 69 hyperprolactinemia 69 gastrointestinal perforation 69 INVEGA ™ 69 nephrotoxicity 69 elevated ALT 69 extrapyramidal symptoms 69 Toxicities 69 ximelagatran 69 QT QTc 69 cardiac repolarization 69 eosinophilia 69 Postoperative complications 69 VAPRISOL 69 renal toxicity 68 nadolol 68 CIMZIA ™ 68 thalidomide Thalomid 68 PRADAXA 68 PREZISTA r 68 riociguat 68 gadobutrol 68 aldosterone antagonist 68 vasogenic edema 68 ATACAND 68 basal bolus regimen 68 thromboembolism 68 atrioventricular block 68 haloperidol Haldol 68 pharmacokinetic interactions 68 BYSTOLIC 68 anticoagulant warfarin 68 neutropaenia 68 MAGE A3 ASCI 68 hyperkalemia 68 pheochromocytoma 68 thyrotoxicosis 68 pancytopenia 68 serum phosphorous 68 pericardial effusion 68 salmeterol fluticasone 68 antimuscarinic 68 myopathy rhabdomyolysis 68 Tasigna prolongs 68 renal insufficiency 68 hepatic enzymes 68 sustained ventricular tachycardia 68 GnRH agonist 68 intravenous bisphosphonates 68 STRIDE PD 68 steroid dexamethasone 68 Febrile neutropenia 68 QT interval prolongation 68 QTc intervals 68 hepatic dysfunction 68 urate lowering 68 QT intervals 68 corrected QT interval 68 tumor lysis syndrome 68 Infusion Reactions Severe 68 INCB# [003] 68 solifenacin 68 Digoxin 68 denileukin diftitox 68 ventricular fibrillation VF 68 Subgroup analysis 68 ARCALYST ® 68 thrombotic thrombocytopenic purpura TTP 67 bezafibrate 67 upper gastrointestinal bleeding 67 aspartate aminotransferase AST 67 adrenal suppression 67 relapsed MM 67 eosinophil count 67 pharmacodynamic parameters 67 tranylcypromine 67 INVEGA ® 67 recurrent venous thromboembolism 67 dopaminergic therapy 67 HER2 overexpression 67 lenalidomide dexamethasone 67 coadministration 67 thromboembolic 67 perioperatively 67 electrophysiologic 67 laboratory abnormalities 67 BENICAR HCT 67 alpha blocker 67 colorectal adenoma 67 reinfarction 67 EDARBI 67 tardive dyskinesia TD 67 myelofibrosis polycythemia vera 67 octreotide LAR 67 hypercholesterolaemia 67 isoproterenol 67 antiarrhythmic 67 Known hypersensitivity 67 teriflunomide 67 lymphopenia 67 metabolic acidosis 67 ECG abnormalities 67 carotid stenosis 67 genotypic resistance 67 hypoglycemic events 67 anaphylactoid reactions 67 hyperalgesia 67 Teriflunomide 67 QTc interval 67 hypocalcemia 67 caspofungin 67 hypersensitivity reaction 67 desvenlafaxine succinate 67 macrolide antibiotic 67 FluCAM arm 67 ertapenem 67 argatroban 67 tolvaptan 67 erythropoietic 67 MULTAQ 67 TMP SMX 67 elotuzumab 67 thrombotic events 67 CANCIDAS 67 aldosterone antagonists 67 virologic breakthrough 67 K ras mutations 67 hematologic parameters 67 quetiapine Seroquel 67 MGd 66 antiemetics 66 ARB telmisartan 66 nicardipine 66 eplerenone 66 lactic acidosis 66 coronary stenosis 66 TNF antagonist 66 tumor necrosis 66 induce orthostatic hypotension 66 biologic DMARD 66 hyperparathyroidism 66 sorafenib Nexavar 66 primidone 66 methemoglobinemia 66 VT VF 66 clinically meaningful reductions 66 GSK# [001] 66 angiographically 66 intracerebral haemorrhage 66 hematological toxicities 66 hepatorenal syndrome 66 Serious Adverse Events 66 anaphylactic reactions bronchospasm 66 morphometric vertebral fractures 66 cardiac toxicity 66 leucopenia 66 prolactin levels 66 cardiac valvulopathy 66 VIIBRYD 66 gastrointestinal toxicities 66 ACTEMRA TM 66 docetaxel chemotherapy 66 oral antidiabetes 66 sitaxsentan 66 Vidaza azacitidine 66 cerebral vasospasm 66 rebleeding 66 liposomal amphotericin B 66 MERLIN TIMI 66 infliximab Remicade 66 neutropenic sepsis 66 calculated creatinine clearance 66 oxycodone CR 66 #mg doses [002] 66 leflunomide 66 macroalbuminuria 66 lichen planus 66 Tindamax R 66 intraventricular 66 PRADAXA #mg 66 surrogate endpoint 66 refractory gout 66 antiarrhythmic drug 66 PR interval prolongation 66 AZILECT 66 Vaprisol 66 NNT = 66 intracranial hemorrhage ICH 66 nonhematologic adverse reactions 66 liver metastasis 66 Hematologic 66 HMG CoA reductase inhibitors 66 ADAGIO study 66 MICARDIS 66 NIASPAN 66 hypomagnesemia 66 corticosteroid therapy 66 D dimer 66 fosbretabulin 66 pyridostigmine 66 recurrent VTE 66 ß blockers 66 definite stent thrombosis 66 delayed gastric emptying 66 Stent thrombosis 66 BANZEL 66 cTnI 66 hematological parameters 66 PROMACTA 66 tamsulosin 66 recurrent glioblastoma multiforme 66 FASLODEX 66 oral antidiabetic 66 triiodothyronine 66 dose limiting toxicities 66 Eltrombopag 66 IFN beta 66 mTOR inhibitors 66 bolus dose 66 Myelosuppression 66 unmeasured confounders 66 Nesiritide 66 sinus tachycardia 66 Xanafide 66 ULORIC 66 PAOD 66 Tolvaptan 66 troponin T 66 mucocutaneous reactions 66 aortic regurgitation 66 cardiac dysfunction 66 troponins 66 plasma kallikrein inhibitor 66 syncope fainting 66 thromboembolic disease 66 paricalcitol 66 neuropsychiatric symptoms 66 ICD shocks 66 ORENCIA ® 66 ZYVOX 66 piroxicam 66 ARCOXIA 66 conjunctival hyperemia 66 Aggrastat ® tirofiban hydrochloride 66 transaminases 66 Erythropoietic therapies may 66 prednisone prednisolone 66 nelfinavir 66 MEVACOR 66 elevated bilirubin 66 sulphonylureas 65 CIMZIA TM certolizumab pegol 65 ribavirin therapy 65 Elitek 65 divalproex sodium 65 hypokalemia 65 postoperative AF 65 eptifibatide 65 ritonavir boosted 65 rosuvastatin #mg 65 RSD# oral 65 intima media thickness 65 postprocedure 65 metabolite concentrations 65 solithromycin 65 LV dysfunction 65 sotalol 65 BARACLUDE ® 65 hydroxychloroquine 65 EDEMA3 trial 65 BEXXAR Therapeutic Regimen 65 NPH insulin 65 DAPT 65 haemolysis 65 overt nephropathy 65 DFMO 65 pulmonary toxicity 65 ancrod 65 calcineurin inhibitors 65 hemostatic efficacy 65 fosamprenavir 65 Peripheral edema 65 cardioembolic stroke 65 abacavir lamivudine 65 LATUDA 65 myocardial ischemia 65 oral antidiabetic medication 65 salmeterol HFA MDI 65 peginterferon alfa 65 voriconazole 65 gemifloxacin 65 Oral corticosteroids 65 hypotensive 65 dose proportionality 65 tumor histology 65 MGUS 65 plasma kallikrein 65 IGFBP 3 65 receiving XGEVA 65 metabolic parameters 65 SGPT 65 arterial thromboembolic events 65 anterior uveitis 65 AGILECT R 65 PRISTIQ 65 Pioglitazone 65 aripiprazole 65 ventricular arrhythmia 65 complement inhibitor eculizumab 65 bronchial hyperresponsiveness 65 intensive statin therapy 65 adrenal insufficiency 65 analgesic medications 65 olmesartan 65 Kepivance 65 PHPT 65 oral Hycamtin 65 chest radiographs 65 unresectable HCC 65 myeloproliferative diseases 65 Primary endpoints 65 prostate cancer PCa 65 iloprost 65 limiting toxicity 65 neutropenia dehydration dyspnea 65 anti coagulant therapy 65 serum cortisol 65 cTnT 65 edifoligide 65 CP CPPS 65 aminotransferase 65 glycosylated hemoglobin HbA1c 65 neutropenia thrombocytopenia 65 Thal Dex 65 periprocedural 65 ACTOS ® 65 asystole 65 neutropenic fever 65 angiographic outcomes 65 serum creatinine levels 65 ACTOplus met XR 65 Hepatocellular Carcinoma HCC 65 cardiac conduction 65 constipation nausea 65 artery stenosis 65 poor metabolizers 65 KRAS status 65 serum aminotransferase levels 65 PEGINTRON TM 65 #mg dose [002] 65 orthostatic hypotension 65 inotropic 65 antidiabetic drugs 65 systemic hypotension 65 Microalbuminuria 65 thrombocytopenic 65 cardiac troponin 65 aspirin clopidogrel 65 revascularizations 65 GnRH agonists 65 invasive candidiasis 65 cangrelor 65 TNF blocker therapy 65 subgroup analyzes 65 transaminase 65 TMS Therapy 65 nausea constipation 65 ventricular repolarization 65 L lysine 65 Pemetrexed 65 infective endocarditis 65 ictal 65 intra abdominal abscess 65 Angioedema 65 oxcarbazepine 65 antiangiogenic therapy 65 DaTscan 65 lanreotide 65 cardiac troponin T 65 intact parathyroid hormone 65 hypoperfusion 65 carcinoids 65 VA# [002] 65 candidemia 65 cediranib 65 NATRECOR R 65 comparator arm 65 Mg Usa 65 thiopurine 65 mitochondrial toxicity 65 micafungin 65 clevidipine 65 Tacrolimus 65 virologic failure 65 teriparatide 65 Bisphosphonate 65 hemorrhagic cystitis 65 Subgroup analyzes 65 T2DM 65 RISPERDAL ® 65 paroxetine Paxil 65 paresthesias 65 nonfatal MI 65 galiximab 65 procalcitonin 65 fulminant hepatitis 65 renal dysfunction 65 neuroleptic malignant syndrome 65 terlipressin 65 pharmacokinetic PK study 65 CYP #A# 65 left ventricular dysfunction 65 thrombocytopenia neutropenia 64 FDG uptake 64 acarbose 64 variceal bleeding 64 antithrombotics 64 VP# [004] 64 ruboxistaurin 64 mucosal lesions 64 FENO 64 Aptivus ® 64 antiepileptics 64 terfenadine 64 MYCAMINE 64 airway hyperresponsiveness 64 bacteriuria 64 transthoracic 64 ZOLINZA 64 TORISEL 64 PASI scores 64 primary aldosteronism 64 alkaline phosphatase ALP 64 Hashimoto thyroiditis 64 non valvular atrial 64 dysrhythmias 64 CrCl 64 hepatic failure 64 thromboembolic complications 64 O PPDS 64 gastrointestinal toxicity 64 flutamide 64 valdecoxib 64 events AEs 64 serum calcium 64 nitrofurantoin 64 PROCRIT ® 64 sonographic diagnosis 64 inhaled corticosteroid therapy 64 tipranavir r 64 CTEPH 64 fatigue asthenia 64 canakinumab 64 pioglitazone HCl 64 neurologic symptoms 64 tiagabine 64 amenorrhoea 64 HPA axis suppression 64 QT interval 64 AVELOX 64 leukopenia 64 aprepitant 64 Tardive dyskinesia 64 glomerular filtration 64 cilostazol 64 events TEAEs 64 liver transaminases 64 Tarceva TM 64 DOXIL 64 treatment emergent AEs 64 sinus bradycardia 64 beta carotene supplementation 64 acitretin 64 multivariate logistic regression 64 Candesartan 64 antitumor effect 64 lymphocytosis 64 intraoperative complications 64 GAMMAGARD 64 multivariate Cox 64 Intussusception 64 hepatitis B immunoglobulin 64 NMIBC 64 alpha interferons 64 macrovascular events 64 antiepileptic drug 64 Amiodarone 64 AVANDIA 64 endophthalmitis 64 alkylating agent 64 histological subtype 64 variant angina 64 HuMax EGFr 64 Dacogen decitabine 64 heparin induced thrombocytopenia 64 F FDG PET 64 sensory neuropathy 64 valvulopathy 64 dermatologic toxicities 64 acromegalic patients 64 myeloperoxidase 64 metformin hydrochloride 64 thrombotic complications 64 gastric adenocarcinoma 64 Cleviprex TM clevidipine 64 IIIa inhibitor 64 intraocular inflammation 64 autonomic dysfunction 64 postoperative mortality 64 sonographically guided 64 HCV SPRINT 64 DAS# CRP 64 pericardial effusions 64 interleukin IL -# 64 epithelial tumors 64 antiarrhythmic drugs 64 ToGA 64 mg kg dose 64 transcranial Doppler ultrasound 64 HBeAg 64 NMDA antagonist 64 dysuria 64 somatostatin analogues 64 hyperbilirubinemia 64 cobiprostone 64 aspartate aminotransferase 64 polycythemia vera PV 64 pimecrolimus cream 64 T1 weighted images 64 insulin detemir 64 oral rivaroxaban 64 nonmelanoma skin cancers 64 arteriography 64 brivaracetam 64 hypersensitivity reactions 64 anti arrhythmic 64 monoclonal gammopathy 64 pharmacokinetic PK 64 elevated serum creatinine 64 pressor response 64 zonisamide SR 64 mcg QD 64 EFFEXOR XR 64 atypical fractures 64 antiplatelet drugs 64 neuroleptic 64 recurrent DVT 64 denervation 64 amphotericin B 64 prucalopride 64 anemia neutropenia 64 alanine aminotransferase 64 thrombophlebitis 64 trastuzumab Herceptin ® 64 H. pylori eradication 64 pathologic fractures 64 beta blocker therapy 64 velafermin 64 diabetic kidney 64 multivariable analysis 64 double blinded placebo 64 ALA PDT 64 tigecycline 64 pegylated liposomal doxorubicin 64 lumiracoxib 64 PREVENT IV 64 mycophenolic acid 64 Akt activation 64 APTIVUS 64 TAXOTERE ® 64 irbesartan 64 severe renal impairment 64 NUCYNTA R 64 RoACTEMRA 64 Perforomist Inhalation Solution 64 ergot alkaloids 64 chemoradiotherapy 64 intracranial hypertension 64 lamotrigine 64 invasive aspergillosis 64 risperidone Risperdal 64 Aflibercept 64 Degarelix 64 Mg Uk 64 zolmitriptan 64 CYT# potent vascular disrupting 64 prostanoid 64 squamous intraepithelial lesions 64 VaD 64 pilocarpine 64 receiving VELCADE 64 Hycamtin ® 64 transaminase levels 64 selective modulator 64 AA Amyloidosis 64 severe neutropenia 64 neurologic progression 64 Atrasentan 64 enalapril 64 eculizumab therapy 64 deferiprone 64 FOLFOX4 64 pharmacokinetic PK profile 64 parkinsonian symptoms 64 adrenocorticotropic hormone 64 varicella infection 64 elevated IOP 64 plasma pharmacokinetics 64 L PPDS 64 Multivariate analysis 64 hepatotoxic 64 dose cohort 64 hyperoxaluria 64 EGFR tyrosine kinase inhibitors 64 SILENOR 64 FOLFOX6 64 NNRTI resistance 64 arterial occlusion 64 Ophena TM 64 tamponade 64 erlotinib Tarceva 64 Elevated liver enzymes 64 IV bisphosphonates 64 ELOXATIN 64 symptom exacerbation 64 serum phosphate 64 Lactic acidosis 64 acute phosphate nephropathy 64 nonrandomized 64 LOVENOX R 64 ergotamine 64 Tekamlo 64 IDH1 mutation 64 tacrolimus ointment 64 anticholinergic medications 64 glucocorticoid therapy 64 Telintra 64 visilizumab 64 trials RCTs 64 vecuronium 64 bisoprolol 64 thrombolytic agents 64 R# #mg BID 64 otamixaban 64 Brugada syndrome 64 sitosterol 64 inflammatory biomarkers 64 somatostatin analog 64 INTELENCE 64 overactive bladder symptoms 64 mucosal inflammation 64 leukoencephalopathy 64 thrombocytosis 64 interstitial pneumonia 64 milrinone 64 eosinophilic pneumonia 64 Non inferiority 64 headache nausea diarrhea 64 systemic corticosteroid 64 antipsychotic efficacy 64 virologic response 64 VFEND 64 INVEGA ® SUSTENNA ® 64 Paliperidone 64 cytogenetic abnormalities 64 pharmacodynamic PD 64 paroxysmal supraventricular tachycardia 64 Cariprazine 64 hyperglycaemia 64 hepatic cirrhosis 64 febrile neutropenia 64 glomerular filtration rate 64 HBeAg positive patients 64 1mg dose 64 ALT AST 64 Telithromycin 64 AVERROES 64 hypoglycemic episodes 64 liver toxicity 64 advanced adenomas 64 abacavir Ziagen 64 pimozide 64 etiologic 64 budesonide foam 64 dyskinesia PD LID 64 gout flares 64 haemodynamic 64 LEVAQUIN 64 overlapping toxicities 64 neurologic complications 64 Kaplan Meier analysis 64 keloid scarring 64 phenytoin 64 renal artery stenosis 64 HCV RESPOND 2 64 histologic subtype 64 coagulation parameters 64 thrombus aspiration 63 dysmenorrhoea 63 SAEs 63 KETEK 63 alfuzosin 63 symptomatic intracranial 63 events SAEs 63 superficial bladder cancer 63 neutropenia febrile neutropenia 63 Inhaled nitric oxide 63 nausea vomiting headache 63 intracerebral hemorrhage 63 antidiabetic drug 63 serum urate levels 63 Mitoxantrone 63 Diovan HCT 63 intravascular hemolysis 63 Warfarin Coumadin 63 hypocalcaemia 63 immunosuppressive regimen 63 Erlotinib 63 Xelox 63 ziprasidone 63 SPRYCEL ® 63 crizotinib PF # 63 antithrombotic therapy 63 Hurthle cell 63 Enzastaurin 63 granisetron 63 metastatic lung cancer 63 XIENCE V PROMUS Stent 63 erythema nodosum 63 itraconazole 63 fulvestrant 63 nonvertebral fracture 63 Rasilez Tekturna 63 exploratory endpoints 63 azacitidine 63 perioperative morbidity 63 hypervascular tumors 63 sertraline Zoloft 63 febuxostat 63 renal scarring 63 memantine Namenda 63 ALT elevations 63 lipid lowering agents 63 certolizumab 63 vandetanib 63 phototoxicity 63 recurrent ischemia 63 ACTOplus met 63 Pharmacokinetic parameters 63 serum calcium levels 63 anti androgen 63 Pulmonary embolism 63 inhaled budesonide 63 pseudomembranous colitis 63 postoperative morbidity 63 atrophic gastritis 63 midazolam Versed 63 composite endpoint 63 postoperative chemotherapy 63 ONGLYZA saxagliptin 63 anakinra 63 enterocolitis 63 ZACTIMA 63 rhythm disturbances 63 CTAP# Capsules 63 leukotriene receptor antagonists 63 CIMZIA TM 63 thioridazine 63 PTHrP 63 NEUPOGEN 63 full thickness plication 63 statins cholesterol lowering 63 clinically meaningful differences 63 ACE Inhibitors 63 tolerability profiles 63 GRNCM1 63 platelet dysfunction 63 oral diclofenac 63 trimethoprim sulfamethoxazole 63 timolol 63 heterozygous FH 63 noncardiac 63 elevated triglyceride levels 63 receiving VICTRELIS 63 neutrophil counts 63 Nocturia 63 parathyroid 63 CIN2 + 63 androgen deprivation 63 choroidal neovascularization CNV 63 glycoprotein IIb IIIa inhibitor 63 RLAI 63 conditional logistic regression 63 dosage regimens 63 hepatic liver 63 alemtuzumab treated 63 montelukast 63 optic neuropathy NAION 63 corticosteroid dose 63 IFN α 63 cardiac tamponade 63 Cystatin C 63 NMDA antagonists 63 receiving INTRON 63 aripiprazole Abilify 63 NOXAFIL 63 stenoses 63 albumin excretion rate 63 atazanavir ritonavir 63 mepolizumab 63 pCR 63 radiographic findings 63 conventional angiography 63 NovoSeven ® 63 deep venous thromboses 63 ocular toxicity 63 atypical antipsychotic medications 63 maximal doses 63 locoregional recurrence 63 TAXUS Stent 63 Parnate 63 SSc 63 urine NGAL 63 pyrazinamide 63 metformin sulfonylurea 63 bleomycin 63 COPEGUS therapy 63 radioiodine therapy 63 nesiritide 63 dermatologic reactions 63 vernakalant hydrochloride 63 Natalizumab 63 hypogonadotropic hypogonadism 63 Adalimumab 63 IXEMPRA 63 immunomodulatory therapy 63 moderate hepatic impairment 63 tipranavir ritonavir 63 RSD# 63 adalimumab Humira 63 receptor inhibitor 63 ATL/TV# 63 Glucocorticoids 63 PML progressive multifocal 63 ziprasidone Geodon 63 postoperative infections 63 postoperative nausea 63 Thalomid ® 63 hypovolemia 63 virological response 63 iodixanol 63 CLORETAZINE TM VNP#M 63 benign prostatic hypertrophy BPH 63 ARIXTRA 63 torsemide ER 63 PEG IFN 63 pulmonary artery catheterization 63 platelet reactivity 63 chlorambucil 63 Lantus insulin 63 MIRAPEX ER 63 Carotid Revascularization Endarterectomy vs. 63 macrovascular disease 63 Insulin PH# 63 sulfasalazine 63 antibody titer 63 PegIntron 63 intravitreal injections 63 plasma uric acid 63 ventricular tachyarrhythmias 63 antithrombotic 63 urodynamic 63 intracranial bleeding 63 HeFH 63 BRIM2 63 Ranolazine 63 nasopharyngitis headache 63 RE LY 63 tricyclic antidepressant 63 androgen suppression 63 epoetin beta 63 transesophageal echocardiography 63 Pseudomonas aeruginosa infections 63 Multivariate logistic regression 63 serum potassium 63 hyperinsulinemic euglycemic clamp 63 receptor tyrosine kinase inhibitor 63 Helicobacter pylori eradication 63 Botox botulinum toxin 63 indinavir 63 TDF FTC 63 Paxil paroxetine 63 fluticasone furoate 63 Vernakalant 63 rt PA 63 angina pectoris 63 intravesical therapy 63 IOP lowering 63 LAB CGRP 63 amifostine 63 haematological toxicity 63 HER2 positivity 63 INVEGA 63 JANUMET 63 elevated creatinine 63 aneurysmal subarachnoid hemorrhage 63 paroxysmal AF 63 INTEGRILIN 63 metastatic malignant 63 elevated plasma concentrations 63 Certolizumab pegol 63 pharmacologic stress 63 ABC/3TC 63 penicillin allergy 63 Moxifloxacin 63 β blocker 63 nonfatal myocardial infarction MI 63 prospectively stratified 63 glatiramer acetate 63 QTcF 63 bronchopulmonary dysplasia 63 hsCRP levels 63 DMARDS 63 beta interferons 63 invasive carcinomas 63 amiodarone 63 testicular tumors 63 Metoprolol 63 Safinamide 63 transfusion syndrome 63 severe exacerbations 63 REBETOL therapy 63 sonographic findings 63 prochlorperazine 63 standard chemotherapy regimen 63 inhaled anticholinergics 63 bronchoalveolar lavage 63 lung metastasis 63 hydrops 63 amisulpride 63 vildagliptin 63 lispro 63 orally inhaled 63 ibandronate 63 angiotensin converting enzyme inhibitor 63 serum urate 63 cefepime 63 Lp PLA 2 63 CRVO 63 GLIADEL R Wafer 63 plasma renin activity